Company
Levitee Labs, Inc.
Headquarters: Vancouver, BC, Canada
CEO: Mr. Philippus Johannes Theodorus van den Berg
Levitee Labs, Inc. Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Levitee Labs Inc. develops and sells mushroom extract nutraceuticals, and supplies and equipment for mushroom cultivation. It operates through two divisions, MONK-E and Sporeo. The MONK-E division produces mushroom-based nutraceutical supplements with a primary focus on mushroom extracts. The Sporeo division produces sterilized spawn and substrates for mushroom cultivation. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Levitee Labs, Inc. has the following listings and related stock indices.
Stock: CSE: LVT wb_incandescent